These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14638809)

  • 21. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of EHEC infection by chitosan nano-structure coupled with synthetic recombinant antigen.
    Khanifar J; Hosseini RH; Kazemi R; Ramandi MF; Amani J; Salmanian AH
    J Microbiol Methods; 2019 Feb; 157():100-107. PubMed ID: 30633949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.
    Russo TA; Beanan JM; Olson R; Genagon SA; MacDonald U; Cope JJ; Davidson BA; Johnston B; Johnson JR
    Vaccine; 2007 May; 25(19):3859-70. PubMed ID: 17306426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.
    Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
    Med Microbiol Immunol; 2019 Feb; 208(1):89-100. PubMed ID: 30209565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic
    Hays MP; Kumar A; Martinez-Becerra FJ; Hardwidge PR
    Front Cell Infect Microbiol; 2016; 6():181. PubMed ID: 28018863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
    Mathieu D; Jacques L; Auer J; Bizzini B
    Biomed Pharmacother; 1987; 41(8):442-5. PubMed ID: 3330459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.
    Sanchez-Villamil JI; Tapia D; Torres AG
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against urinary tract infection with a multi-valent vaginal vaccine.
    Uehling DT; James LJ; Hopkins WJ; Balish E
    J Urol; 1991 Jul; 146(1):223-6. PubMed ID: 2056594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico analysis and recombinant expression of BamA protein as a universal vaccine against Escherichia coli in mice.
    Guan Q; Wang X; Wang X; Teng D; Wang J
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):5089-98. PubMed ID: 27020285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor.
    Léveillé S; Caza M; Johnson JR; Clabots C; Sabri M; Dozois CM
    Infect Immun; 2006 Jun; 74(6):3427-36. PubMed ID: 16714573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.
    Sarkissian CA; Alteri CJ; Mobley HLT
    Vaccine; 2019 Aug; 37(35):4937-4946. PubMed ID: 31320216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157.
    Fox JT; Thomson DU; Drouillard JS; Thornton AB; Burkhardt DT; Emery DA; Nagaraja TG
    Foodborne Pathog Dis; 2009 Sep; 6(7):893-9. PubMed ID: 19737065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):141-5. PubMed ID: 23102992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.